UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSE
1576
DELISTED
Trinseo
TSE
| $2.3M | ﹤0.01% |
44,890
+2,764
| +7% | +$105K |
|
|
FSP
1577
Franklin Street Properties
FSP
$46.4M
| $2.3M | ﹤0.01% |
525,609
+119,834
| +30% | +$529K |
|
|
VRTU
1578
DELISTED
Virtusa Corporation
VRTU
| $2.28M | ﹤0.01% |
44,537
+21,869
| +96% | +$1.1M |
|
1579
Rambus
RMBS
$10.4B
| $2.28M | ﹤0.01% |
130,321
+4,662
| +4% | +$73.1K |
|
|
MFA
1580
MFA Financial
MFA
$931M
| $2.26M | ﹤0.01% |
145,374
+3,275
| +2% | +$44.2K |
|
1581
Amkor Technology
AMKR
$13.3B
| $2.25M | ﹤0.01% |
149,339
+322
| +0.2% | +$4.39K |
|
1582
O-I Glass
OI
$1.1B
| $2.25M | ﹤0.01% |
188,871
-11,923
| -6% | -$136K |
|
|
CTB
1583
DELISTED
Cooper Tire & Rubber Co.
CTB
| $2.24M | ﹤0.01% |
55,344
-314
| -0.6% | -$12K |
|
1584
ESCO Technologies
ESE
$7.77B
| $2.24M | ﹤0.01% |
21,686
-897
| -4% | -$84.5K |
|
1585
Equinox Gold
EQX
$13.6B
| $2.22M | ﹤0.01% |
214,777
+21,100
| +11% | +$230K |
|
1586
LGI Homes
LGIH
$1.33B
| $2.22M | ﹤0.01% |
20,933
-431
| -2% | -$49.1K |
|
|
TWO
1587
Two Harbors Investment
TWO
$1.26B
| $2.22M | ﹤0.01% |
86,933
+7,702
| +10% | +$183K |
|
1588
First Majestic Silver
AG
$9.22B
| $2.21M | ﹤0.01% |
164,940
| – | – |
|
1589
Northwest Natural Holdings
NWN
$2.11B
| $2.21M | ﹤0.01% |
48,015
-7,136
| -13% | -$338K |
|
|
WBT
1590
DELISTED
Welbilt, Inc.
WBT
| $2.2M | ﹤0.01% |
166,920
+37,057
| +29% | +$333K |
|
1591
Axsome Therapeutics
AXSM
$11.4B
| $2.2M | ﹤0.01% |
27,043
-630
| -2% | -$47.1K |
|
1592
WaFd
WAFD
$2.8B
| $2.2M | ﹤0.01% |
85,405
-6,188
| -7% | -$147K |
|
|
INFN
1593
DELISTED
Infinera Corporation Common Stock
INFN
| $2.19M | ﹤0.01% |
209,202
+43,862
| +27% | +$348K |
|
1594
Atkore
ATKR
$3.17B
| $2.19M | ﹤0.01% |
53,322
+5,284
| +11% | +$167K |
|
1595
Healthcare Services Group
HCSG
$1.47B
| $2.19M | ﹤0.01% |
77,857
+708
| +0.9% | +$17.1K |
|
1596
eHealth
EHTH
$39.4M
| $2.18M | ﹤0.01% |
30,930
+1,572
| +5% | +$119K |
|
|
AGNT
1597
AGNT Inc
AGNT
$717M
| $2.18M | ﹤0.01% |
69,016
+11,252
| +19% | +$311K |
|
|
DOOR
1598
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.17M | ﹤0.01% |
22,061
+2,722
| +14% | +$264K |
|
|
AZRE
1599
DELISTED
Azure Power Global Limited
AZRE
| $2.17M | ﹤0.01% |
53,145
+36,937
| +228% | +$1.17M |
|
|
ITCI
1600
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.15M | ﹤0.01% |
67,644
+15,942
| +31% | +$419K |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.